AMT 2003
Alternative Names: AMT - Auron; AMT-2003; Auron Misheil TherapyLatest Information Update: 10 Aug 2011
At a glance
- Originator Auron Healthcare
- Class Antineoplastics
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Cervical cancer; Colorectal cancer; Liver cancer; Solid tumours